Memphasys Ltd
Memphasys Signs Distribution Deal for Felix Fertility Device into IVF Clinics throughout Vietnam
Memphasys inks $530,000 Vietnam deal to distribute Felix fertility device through TMSC Vietnam, marking first SE Asia partnership and rapid IVF market expansion.
Memphasys Prepares for First Australian Sales after Felix Sperm Separation Device Gains TGA Approval
Memphasys (ASX: MEM) gains TGA approval for Felix device, enabling immediate Australian sales and clinic deployments two months ahead of schedule.
Memphasys Secures CE Mark for Felix System, Unlocking European Market
Memphasys (ASX: MEM) has secured CE Mark approval for its Felix System, unlocking immediate commercial opportunities in Europe and activating binding multi-year contracts in Europe and MENA.
Memphasys Signs Agreement to Distribute Felix Fertility Device Across Middle East and North Africa
Memphasys (ASX: MEM) has granted Qatar-based company International Technical Legacy (ITL) exclusive commercial and distribution rights to its innovative Felix male fertility sperm preparation system. The five-year deal applies to approximately 353 clinics across 15 countries across the Middle East and North Africa, which perform a cumulative 140,000 in vitro fertilisation (IVF) cycles per year. […]